Creative Medical Technology Holdings (CELZ) EPS (Basic) (2010 - 2026)
Creative Medical Technology Holdings' (CELZ) quarterly EPS (Basic) came in at -$1.09 in Q2 2026, down 22.54% year-over-year from -$1.4 in Q2 2025, and down 7.66% quarter-over-quarter from -$1.01 in Q1 2026.
Powered by 
Analysis
Creative Medical Technology Holdings (CELZ) EPS (Basic) (2010 - 2026) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported EPS (Basic) for 17 consecutive years, with -$1.09 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EPS (Basic) fell 22.54% year-over-year to -$1.09 in Q2 2026; TTM through Jun 2026 was -$5.22, a 5.55% decrease from a year earlier, with the FY2025 full-year figure at -$5.19, down 9.24% from the prior year.
- EPS (Basic) was -$1.09 for Q2 2026 at Creative Medical Technology Holdings, down from -$1.01 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.7 in Q3 2022 and troughed at -$5.69 in Q4 2022.
- A 5-year average of -$1.44 and a median of -$1.05 in 2023 frame the typical range for EPS (Basic).
- The widest YoY moves for EPS (Basic): up 90.71% in 2022, down 101.46% in 2022.
- Over 5 years, EPS (Basic) stood at -$5.69 in 2022, then surged by 79.03% to -$1.19 in 2023, then sank by 79.3% to -$2.14 in 2024, then decreased by 4.81% to -$2.24 in 2025, then surged by 51.56% to -$1.09 in 2026.
- The last three EPS (Basic) figures came in at -$1.09 (Q2 2026), -$1.01 (Q1 2026), and -$2.24 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 1.85 |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | -0.94 |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | -0.11 |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 0.42 |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | -1.22 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | -1.18 |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 0.06 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -0.05 |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 0.04 |
| 10 | Creative Medical Technology Holdings | 1.45 Mn | 1.45 Mn | - | -1.09 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.09 |
| Mar 31, 2026 | -1.01 |
| Dec 31, 2025 | -2.24 |
| Sep 30, 2025 | -0.89 |
| Jun 30, 2025 | -0.89 |
| Mar 31, 2025 | -1.18 |
| Dec 31, 2024 | -2.14 |
| Sep 30, 2024 | -0.75 |
| Jun 30, 2024 | -1.11 |
| Mar 31, 2024 | -0.73 |
| Dec 31, 2023 | -1.19 |
| Sep 30, 2023 | -1.02 |
| Jun 30, 2023 | -0.78 |
| Mar 31, 2023 | -0.75 |
| Dec 31, 2022 | -5.69 |
| Sep 30, 2022 | -0.70 |
| Jun 30, 2022 | -1.99 |
| Mar 31, 2022 | -1.79 |
| Dec 31, 2021 | -14.88 |
| Sep 30, 2021 | -7.52 |